Tag Archives: HEA

PR Newswire

Welcome to NETX – Global Conglomerate Bellagraph Nova Group Launches Latest Technolgy Platform Focusing on AI + Robotics + Healthcare

Leave a comment

PARIS, July 10, 2020 — Headquartered in Paris, France, the Bellagraph Nova Group (BN Group), the multi-national conglomerate overseeing 31 business entities across 100 countries is the world’s fastest growing 360 degree lifestyle platform. 

The BN Group is proud to announce its latest project to its ever-increasing portfolio: NETX, an exciting new division focused on the development and application of robotics and Artificial Intelligence (AI) technology. 

In December 2019, the three founders of the BN Group, Terence Loh, Nelson Loh, and Evangeline Shen hosted a closed door discussion session with Barack Obama, the 44th President of the United States of America to discuss their views on how technology will bring about the next industrial revolution. The three founders passionately shared their vision where technological disruption is essential to bringing about positive change in our society. As a result of their historic meeting with Barack Obama, NETX was born … The rest as they say is history.

(L-R) Bellagraph Co-Founders Nelson Loh, Evangeline Shen, President Barack Obama and Terence Loh having an engaging discussion on how the BN Group wants to harness technology to benefit mankind
(L-R) Bellagraph Co-Founders Nelson Loh, Evangeline Shen, President Barack Obama and Terence Loh having an engaging discussion on how the BN Group wants to harness technology to benefit mankind

In President Obama’s own words, ” What we’re seeing here is the way that technology is changing not just how you do business, not just how you buy products, but also how you interact, how you organize politically, how you get involved in the community and how you solve problems. And all of that can support millions of new jobs.”

Those very own words of President Obama prompted the three founders’ subsequent quote: “Following our meeting with President Obama in Dec 2019, the three of us were greatly inspired by his vision. It resonated strongly with ours, so much so our exhilarated actions led to the launch of NETX.” Over the last 6 months, it has been a primary focal point of the BN Group to channel its energy and global resources into the development and commercialization of the rapidly growing global robotics market which is forecast to grow to over US$160 billion by 2025. Especially in light of the post COVID-19 pandemic, the global adoption of AI and robotics will be even faster and across all aspects of our lives.

During the COVID-19 pandemic, NETX already dispatched domestic service robots to support frontline healthcare workers worldwide, protecting over 80,000 patients and medical staff. NETX has also implemented AI in its Remote Access technology which has greatly reduced the risk of exposure in otherwise hazardous conditions. In seeing the successful applications of NETX’s robotics and AI technology, the BN Group is planning the distribution and implementation of NETX to the company’s worldwide network of hospitals, clinics, commercial and retail locations.

While many questions still remain unanswered regarding the world of robotics and how these machines will affect society, there should be no question of the Bellagraph Nova Group’s unwavering commitment to simply making our world a better place by investing in the future with its focus on the development and application of robotic technology in its latest exciting chapter, NETX.

ABOUT BELLAGRAPH NOVA GROUP

Sustainability, diversity and ethics, constitute the cornerstone of BN Group’s model and compliance policy for its executives, employees and stakeholders. Our emblem is the butterfly, the symbol par excellence of endurance and perennial metamorphosis.

The Group is headquartered in the famous 10 Place Vendôme in Paris, France. With 31 entities in over 100 countries, the combined US$12 billion revenue Bellagraph Nova Group is the world’s fastest growing 360 degree lifestyle platform.

Photo – https://photos.prnasia.com/prnh/20200710/2854757-1?lang=0
Logo – https://photos.prnasia.com/prnh/20200707/2850183-1logo?lang=0

PR Newswire

Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery

Leave a comment

Mathematical Breakthrough by Australia-based Research Team Leads to a Shortening of Drug Discovery Times and Efficacy Analysis

SYDNEY and MELBOURNE, Australia, July 10, 2020 — Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceutical software platform called Pharma Leads https://carromex.com/products/pharma-leads/, that is set to significantly contribute to the advancement of the healthcare and pharmaceutical industry today. 

The platform provides pharmaceutical companies and researchers with two unique benefits: 

  • First, users can discover potential treatments by merely inputting the genetic sequence of the disease, dramatically reducing the time and costs associated with searching for new treatments.
  • Second, researchers and pharmaceutical companies can rapidly assess the safety and efficacy of the therapy by analyzing its genetic makeup to test if the combination will be harmful to the body.

The discovery was first made by Dr Burzin Bhavnagri while in pursuit of his Ph. D. at the University of Adelaide and is now available publicly for the first time. 

"Representational Consistency is an exciting and entirely new field of mathematics. In my thesis on the development of "Computer Vision using Shape Spaces" and my desire to apply the theory to a real-world example of cancer drug treatment, I discovered a formula which led to the creation of Pharma Leads", said Dr. Burzin.

From the Search for a Cure for Cancer to a Healthcare Breakthrough

In 2012, using his discovery of Representational Consistency, Dr Burzin began to research the 30 known definite carcinogens listed by the International Agency of Cancer Research (IARC), where he discovered a link between representational inconsistency and carcinogens, prompting the search for a cancer treatment using the theory. 

Dr Burzin then discovered that the same process could be used to dramatically reduce the research time and costs associated with drug development and discovery, leading to the creation of the Pharma Leads platform. 

Using Computer Vision to Revolutionize the Pharmaceutical Industry

Pharma Leads by Carromex is an interactive online program that works in silico without the need for a database which can systematically analyze a chemical structure or gene sequence. 

The revolutionary platform allows users to access a list of amino acids for a protein sequence or a list of nucleic acids for a gene sequence. The user can also enter the name of the medicines or their chemical structure to analyze a drugs safety and efficacy. 

"Users can choose from searching for a treatment or analyze how a chemical compound may interact with RNA or DNA, for instance, Acetaminophen," Dr Burzin explained further. 

Pharma Leads by Carromex is currently available on Google Cloud for users in the United States. 

For more information, please visit https://carromex.com/products/pharma-leads/ 

About Carromex and the Invention of Pharma leads 

Carromex was founded in the 1980s by the late Dr Nina Bhavnagri and her son Dr Burzin Bhavnagri. For the last eight years, the company has been focusing on mathematical research and program design. 

Related Links :

http://www.carromex.com

PR Newswire

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

Leave a comment

SHANGHAI and SAN DIEGO, July 9, 2020 — WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series “Collaborations That Transform,” highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary webinar, to be broadcast worldwide on July 16, will convene leading physicians, drug developers, patients and advocates. These experts will discuss the latest advances in the development of transformative medicines for hemophilia, including gene therapy and next generation technologies.

As an enabler of the biotech and medical device industry, WuXi AppTec shares the conviction that we must work collaboratively to solve industry-wide problems and bring transformational medicines to people living with rare diseases. On July 16, the webinar will continue the dynamic discussions that began with WuXi AppTec’s inaugural rare disease webinar in May. It is complimentary and open to the public.

WuXi AppTec welcomes all to join the conversation.

Register Now: https://www.eventbrite.com/e/collaborations-that-transform-advances-in-rare-diseases-hemophilia-tickets-112318908880?aff=Content 

AGENDA (Eastern Daylight Time).

10:30 Welcome

10:35 – 11:00 Addressing the Unknowns in an Era of Transformations

  • A conversation with Glenn Pierce, VP Medical, World Federation of Hemophilia, Entrepreneur-in-Residence at Third Rock Ventures, and Chief Medical Officer at Ambys Medicines; moderated by Hui Cai, VP and Head of Content Division, WuXi AppTec

11:00 – 12:00 The Quest for Transformative Medicines

  • Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics
  • John Pasi, Professor of Haemostasis and Thrombosis, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
  • Richard Pezzillo, Executive Director, New England Hemophilia Association
  • Glenn Pierce, VP Medical, World Federation of Hemophilia
  • Rogerio Vivaldi, President & Chief Executive Officer, Sigilon Therapeutics
  • Guy Young, Director, Hemostasis and Thrombosis, Children’s Hospital Los Angeles; Professor of Pediatrics, University of Southern California Keck School of Medicine
  • Moderated by Richard Soll, Head of WuXi AppTec’s Boston office; Senior Advisor of Strategic Initiatives

12:00 Closing

Related Links :

http://www.wuxiapptec.com

PR Newswire

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Leave a comment

Paige leveraged the world’s largest dataset in pathology to develop an unparalleled computation pathology offering

SANTA CLARA, California, July 8, 2020 — Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizes Paige with the 2020 North American Enabling Technology Leadership Award for its disruptive product offering.

Paige
Paige

Paige has developed robust machine learning models for computational pathology for detecting cancer subtypes, thereby enhancing the diagnosis capability of pathologists worldwide. Paige’s AI-based technology was developed and tested on over 100,000 de-identified, digitized slide images from more than 16,000 cancer patients. The deep learning algorithms detected prostate cancer, skin cancer, and breast cancer with near-perfect accuracy.   

“Paige’s AI algorithms validated against the world’s largest dataset in pathology makes it the most trustworthy best in class pathology diagnosis solution,” said Debarati Sengupta, Industry Analyst, Frost & Sullivan. “Paige’s technology eliminates the need to curate datasets, which is time-consuming and expensive. Paige’s AI based pathology offering enables pathologists to make a fast and accurate diagnosis of even the most complex and difficult to interpret slides.”

The Paige offering consists of general and organ-specific products that provide rapid diagnostic stratification, cancer detection, tumor segmentation, and prediction of treatment response, and overall survival. Its algorithms form a portfolio of AI-based digital diagnostics and biomarkers to help pathologists provide diagnoses. For security purposes, all datasets used to build the products were de-identified, and any protected health information or label text was removed.

Notably, Paige’s computational pathology offering received the Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2019, making it the first such device for cancer diagnosis. Furthermore, it began commercializing in 2019 following its CE mark approval for Paige Prostate, which is a first-to-market prostate cancer detection solution, and a digital pathology viewer for the primary diagnosis of any digital slide. Paige’s AI-based solutions are vendor agnostic, which helps it serve a wider pool of customers.

In 2020, it formed a strategic partnership with Invicro LLC, a Konica Minolta company to provide its AI-based integrated pathology solutions to support Invicro’s drug discovery and development initiatives. “Paige continues to expand its footprint not just in commercial laboratories, but also in biopharmaceutical companies, positioning itself as a pioneer in AI-based digital pathology market” noted Sengupta.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Kristen Moore
P: 210.247.3823
E: kristen.moore@frost.com

About Paige
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center.  The Company builds computational pathology products designed so patients and their care teams can make faster, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity.  Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy. Our products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first and only company to receive FDA breakthrough designation for computational pathology products.

For additional information, please visit:  https://www.Paige.ai  Twitter and LinkedIn

Media Contact:
NRPR Group
Nicole Rodrigues
(650) 815-5069
nicole@nrprgroup.com

Related Links :

http://www.frost.com

PR Newswire

Xovis Multiplies Your Options in One Fell Swoop

Leave a comment

Two new AI features for in-store analytics made possible by Xovis 3D sensors

ZOLLIKOFEN, Switzerland, July 2, 2020 — When their ordinary "all-in-a-day’s-work" became extraordinary, Xovis ramped up their R&D to solve unforeseen challenges. Today, the company proudly presents two new AI features for their 3D people counting sensors: Face Mask Detection and View Direction. While View Direction had been hinted at in January this year, Face Mask Detection has sprung up out of the current situation with COVID-19. Xovis hopes that this will help their customers stay on top of public health regulations. The company’s innovative and GDPR compliant technology becomes the only kind to detect face masks directly on 3D sensors.

The Xovis Face Mask Detection
The Xovis Face Mask Detection

 

The Xovis View Direction
The Xovis View Direction

As Xovis Head of Retail Anne Wyder explains, "COVID-19 has made face masks compulsory in many public places; we have responded by developing a new AI feature for our sensors to recognize whether or not face masks are in fact being worn. In a bid to help businesses adhere to public health regulations, this new software plugin for Face Mask Detection will be free of charge until the end of the year for our integrator partners working with the Xovis Cloud Account." 

Despite COVID-19, and at the same time because of the global crisis that has ensued, Xovis is actively providing technological solutions for both occupancy and physical distancing management. As Xovis CPO Christian Studer puts it: "We have been busy – we’ve not only finished development of the much-anticipated View Direction plugin for in-store analytics, but in an agile response to changing market demands also stepped up to the plate and created something extra in our firmware for our customers. Both Face Mask Detection and View Direction features provide deeper insight into customer behavior – the analysis of which has become more important than ever before."

As the undisputed innovator of people flow technology based on 3D stereovision sensors, Xovis is committed to bringing the best products and services to customers and partners alike. Because people count.

See how Xovis detects Face Masks

Read how Xovis View Direction works

Click here for more about Xovis Physical Distancing Solutions

Photo – https://techent.tv/wp-content/uploads/2020/07/xovis-multiplies-your-options-in-one-fell-swoop-3.jpg  
Photo – https://techent.tv/wp-content/uploads/2020/07/xovis-multiplies-your-options-in-one-fell-swoop.jpg  
Logo – https://techent.tv/wp-content/uploads/2020/07/xovis-multiplies-your-options-in-one-fell-swoop-2.jpg

Company Contact
Xovis
Industriestrasse 1
3052 Zollikofen
Switzerland
+41-32-342-04-70
info@xovis.com

Media Contact
Christian Studer, CPO
+41-32-508-35-41
christian.studer@xovis.com

Related Links :

https://www.xovis.com/

PR Newswire

Neusoft Ranks Top in China Healthcare IT Solutions Market for Ten Consecutive Years

Leave a comment

SHENYANG, China, July 2, 2020 — Recently, International Data Corporation (IDC) has released the China Market Shares of Core Hospital Management Systems 2019: Upgrading Core Systems to Support Healthcare Digital Transformation. According to this report, Neusoft took the first place in China core hospital management systems solutions market in 2019 and topped the ranking of China healthcare IT solutions market for the tenth consecutive year, continuing leading the healthcare informatization construction in China.

In the healthcare informatization sector, Neusoft is a leading provider of intelligent healthcare integrated solutions in China. With the largest client base in the industry in China as well as the best practices in various sub-sectors, Neusoft is striving to facilitate the rapid development of healthcare informatization and promoting China’s healthcare system reform. Neusoft is also the first large provider to have launched core hospital management systems, with leading market shares as well as advanced concepts and products.

With over two decades’ devotion to the healthcare sector, Neusoft consistently commits itself to utilizing information technologies to promote the harmonious development of the healthcare ecosystem. Nowadays, Neusoft’s healthcare business has covered hospital informatization, health insurances, medical equipment, cloud hospitals, medical big data and intelligence, health and medical education, medical IoT and 5G, etc., and Neusoft has built a sustainable IT-centric ecosystem.

In the future, Neusoft will continue to empower the healthcare industry through software. Neusoft will keep promoting the integration of information technology and the healthcare, make the new technologies like artificial intelligence, blockchain, cloud computing, big data, internet of things become new medical elements, and build a sustainable healthcare ecosystem for creating more value for the society, industry and clients.

Related Links :

http://www.neusoft.com/en

PR Newswire

Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group

2 Comments

Businesses and workers call for greater flexibility, questions raised over the hours-based contract, and a new empathetic leadership profile emerges

ZURICH, June 30, 2020 —

  • Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal
  • Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather than hours worked
  • Boom in digital skills an unintended consequence of lockdown, with tech knowhow improving for six in 10 (61%), and two thirds (69%) eager for further digital upskilling post-pandemic
  • Leaders need to reinvent themselves as more emotionally intelligent, but they are not prepared, as less than half felt equipped to support employees holistically during the pandemic

The coronavirus pandemic has resulted in pivotal shifts in attitudes and expectations among workers and leaders, as both call for permanent changes in how and where we work, workplace relationships and future skills, according to new research from the Adecco Group.

The Adecco Group, the world’s leading HR solutions company, today unveiled the results of its latest study, Resetting Normal: Defining the New Era of Work, examining the expected short- and long-term impact of the pandemic on resetting workplace norms. Fieldwork was conducted in May 2020, with 8,000 office-based respondents (aged 18-60) across Australia, France, Germany, Italy, Japan, Spain, the UK and the USA.

The Adecco Group’s Chief Executive Officer, Alain Dehaze, said: “The world of work will never return to the ‘normal’ we knew before the pandemic struck. The sudden and dramatic change in the workplace landscape has accelerated emerging trends such as flexible working, high-EQ leadership, and re-skilling, to the point where they are now fundamental to organisational success. As many countries emerge from the acute crisis phase of the pandemic, employers have an opportunity to ‘hit reset’ on traditional workplace practices – many of which have remained largely unchanged since the industrial revolution. This research highlights that employee attitudes have shifted and gaps between workforce expectations and entrenched labour market processes have been exposed. As we step into the new era of work, now is the time to establish better norms that will enable a holistically healthy, productive and inclusive workforce into the future.”

Key research highlights:

The research revealed that the working world is ready for a new “hybrid” model, with three quarters (74%) of workers surveyed saying a mix of office-based and remote working is the best way forward. The universal ideal of spending half (51%) of their time in the office and half working remotely (49%) transcends geographies, generations and parental status. And company executives agree, with almost eight in ten (77%) C-suite leaders saying businesses will benefit from increased flexibility.

Another stark finding could signal the end of the hours-based contract and 40-hour week. More than two thirds (69%) of workers are in favour of “results-driven work,” whereby contracts are based on delivering against business needs rather than working a set number of hours. A high proportion of C-suite executives (74%) agree that the length of the working week should be revisited.

The pandemic has also demanded a new set of leadership competencies and these expectations are expected to accelerate a reinvention of the modern-day leader. Emotional intelligence has clearly emerged as the defining trait of today’s successful manager, but the soft skills gap is evident. Over a quarter (28%) of those questioned said their mental wellbeing had worsened due to the pandemic, with only 1 in 10 rating their managers highly on their ability to support their emotional health.   

In a similar nature to flexible working, the findings demonstrate a universal appetite for mass upskilling. Six in 10 say their digital skills have improved during lockdown, while a further two thirds (69%) are looking for further digital upskilling in the post-pandemic era. A broad range of skills development were identified as important by the workforce, including managing staff remotely (65%), soft skills (63%) and creative thinking (55%).

Finally, the findings highlighted the importance of sustaining trust in the new working world. Companies have risen to the challenge of supporting their people during the crisis, and as a result, trust in corporations has increased. In fact, 88% say that their employer met or exceeded their expectations in adapting to the challenges of the pandemic. And with this increased trust comes increased expectations. While the future of work is a collective responsibility, 80% of employees believe their employer is responsible for ensuring a better working world post-COVID and resetting norms, compared with 73% who say the government is responsible, 72% who agree it is an individual responsibility, and 63% who believe it is in the hands of labour unions.

For more information: 

  • Download the Resetting Normal: Defining the New Era of Work full report here.
  • Follow us on social #ResetNormal for updates 

About the Adecco Group

The Adecco Group is the world’s leading HR solutions company. We believe in making the future work for everyone, and every day enable more than 3.5 million careers. We skill, develop, and hire talent in 60 countries, enabling organisations to embrace the future of work. As a Fortune Global 500 company, we lead by example, creating shared value that fuels economies and builds better societies. Our culture of inclusivity, entrepreneurship and teamwork empowers our 35,000 employees and we are proud to have been consistently ranked one of the ‘World’s Best Workplaces’ by Great Place to Work®. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN) and powered by nine global brands: Adecco, Adia, Badenoch & Clark, General Assembly, Lee Hecht Harrison, Modis, Pontoon, Spring Professional and Vettery.

adeccogroup.com
Facebook: facebook.com/theadeccogroup
Twitter: @AdeccoGroup

Logo – https://techent.tv/wp-content/uploads/2020/06/sweeping-workplace-changes-expected-in-a-post-pandemic-world-says-research-from-the-adecco-group.jpg

For further information please contact:
The Adecco Group Press Office
media@adeccogroup.com
+41-(0)-44-878-87-87

Related Links :

https://www.adeccogroup.com

PR Newswire

VeChain Powers DNV GL’s My Care: A Hospital-grade Infection Risk Management Solution

Leave a comment

SHANGHAI, June 27, 2020 — With the COVID-19 pandemic threatening individuals and businesses worldwide, infection risk management has been a tough challenge. To help companies better handle this problem, DNV GL, one of the world’s largest assurance companies with over 15,000 professionals globally and over 110,000 customers, has designed, developed and released a blockchain-enabled infection risk management solution called My Care, which aims to assess, manage and mitigate infection risk in management processes, business dealings and operations for enterprise users.


This new initiative and product by DNV GL will be enhanced and powered by VeChain’s blockchain technology. In particular, the VeChain ToolChainTM BaaS Platform will be used to support DNV GL to launch this brand-new digital product in a rapid lead time.

First enterprise level customer to take advantage of this new solution is Viking Line, a publicly traded shipping company with an annual revenue of ~EUR 500 million.  On June 17th, 2020, the company Viking Line announced to use My Care. More companies are expected to be on-board as DNV GL expands the scope of the product and enterprise adoption efforts.

VeChain Enhances DNV GL’s Digital Transformation Strategy

Since the announcement of our strategic partnership in January 2018, the collaboration between VeChain and DNV GL has been progressively promoting the adoption of blockchain to help enterprises bolster the transparency and trust between their customers and products. VeChain has been the infrastructural technology behind the various blockchain powered initiatives offered by the DNV GL portfolio of services.

By using VeChain ToolChainTM, DNV GL took the first step in May 2019 to develop its My StoryTM, a digital assurance solution that aims to track each stage of a product’s manufacturing cycle with the use of blockchain technology. My StoryTM is just one of the many different VeChain-powered services that DNV GL offers.

My Care To Assist COVID-19 Infection Risk Management

As the world grapples with COVID-19, managing infection risk requires a new approach to disease control and prevention, and new operating procedures and assurance practices would need to be introduced. This led to the introduction of My Care to assist companies on preparedness and readiness of infection risk management.

With the combination of standard templates, customizable tools, data value visualization tools and third-party certification services, VeChain ToolChainTM has been the technical foundation for different digital solutions. DNV GL’s My Care is another one of them that will utilize the VeChainThor blockchain for all data related purposes.

A Hospital-Grade Solution To Resolve COVID-19 Pain Points In Enterprises

The My Care methodology is derived from the approach DNV GL applies to assess infection risk management in hospitals. The solution is a suite of independent assessment services designed to help businesses reassure stakeholders that they have put infection risk management at the core of their risk management strategy. It brings together aspects of DNV GL’s healthcare standards, best practices in risk management, HSE (health, safety, and environment) and quality management systems and maturity safety rating standards.

For customers and other stakeholders, scanning the QR-code embedded in the My Care trust mark will provide users access to DNV GL’s assessment statement. These assessment statements are stored on VeChainThor blockchain, providing added trust and integrity. With blockchain, businesses can be assured that their infection risk management and best practices is effectively communicated to customers.

For enterprises looking to return to business, My Care’s holistic approach affirms its capability to manage and prevent infection risks, including COVID-19, enables readiness to deal with infectious diseases today and can drive lasting changes that build long-term business resilience.

Blockchain Powered Solutions To Further Expand On A Global Scale

As a major emerging technology in various industries, blockchain is quickly bringing about further digitization in the business world, which is an opportunity for both VeChain and DNV GL to further enhance our strategic partnership and facilitate business growth.

VeChain ToolChainTM has been receiving acknowledgement from various industries as a solution for persistent problems that hold back business growth, such as sustainability management, supply chain optimization, responsible manufacturing, and real-time asset flows.

Sunny Lu, co-founder and CEO at VeChain stressed, “As we contend with the new normal due to COVID-19, the demand for trust has never been so important. Blockchain will be one of the driving forces to increase confidence in data integrity, business credibility, and mutual trust in multi-party collaboration. With VeChain ToolChainTM, we have great confidence to support DNV GL’s digital transformation strategy to develop more digital solutions like My StoryTM and My Care to expand and improve their offerings to serve their clients worldwide.”

About VeChain

Launched in 2015, VeChain connects blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model, and IoT integration. VeChain is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco. Together with our strategic partners PwC and DNV GL, we have established cooperative relations with many leading enterprises in different industries, including Walmart China, BMW, BYD Auto, Haier, H&M, LVMH, D.I.G, ENN, Shanghai Gas, AWS, PICC, ASI etc.

For further information:

https://www.dnvgl.com/services/my-care-keeping-you-safe-assess-manage-and-mitigate-infection-risk-and-build-stakeholder-trust-176161

Scan to check the readiness statement of Viking Line verified by DNV GL
Scan to check the readiness statement of Viking Line verified by DNV GL

Photo – https://techent.tv/wp-content/uploads/2020/06/vechain-powers-dnv-gls-my-care-a-hospital-grade-infection-risk-management-solution-3.jpg
Photo – https://techent.tv/wp-content/uploads/2020/06/vechain-powers-dnv-gls-my-care-a-hospital-grade-infection-risk-management-solution.jpg
Logo – https://techent.tv/wp-content/uploads/2020/06/vechain-powers-dnv-gls-my-care-a-hospital-grade-infection-risk-management-solution-2.jpg

Related Links :

http://www.vechain.com

PR Newswire

A Korean startup has an advanced QR tracing solution to possibly stop COVID-19 2nd wave, and it’s looking to donate the solution

Leave a comment

Nationwide deployed QR code tracing system would be effective in case of second surge of COVID-19

SEOUL, South Korea, June 25, 2020 — A cybersecurity startup and a member company of the Born2Global Centre, swlDch suggests dynamic, unidirectional QR code technology that can encourage wider user adoption as well as protect user privacy.

Strict measures are eased as the number of COVID-19 cases is falling. However, concerns remain that further surges of cases may be on the horizon. Even countries with effective strategies have seen second wave spikes and clusters of cases. So when the World Health Organization says the virus may be here to stay, nations need to understand that they will experience new cases. The challenge is how to predict, track and handle them. It is crucial to keep test and trace momentum to manage the epidemic in a timely manner. Under this circumstance, many governments try to adopt contact-tracing app on a national scale. In the UK, a new NHS contact-tracing app will be in place. The app allows smartphones to track every other device they have come into contact with, exchanging anonymous IDs using Bluetooth signal. Once the case is confirmed, it then informs other users in close contact through the app.   

South Korea is taking a slightly different approach. They focus on tracking visitors at high-risk facilities by adopting a QR Code based electronic registration system. This became compulsory because South Korean authorities have experienced considerable difficulties in their epidemiological investigation of the night club outbreak in May. Much of the information on handwritten visitor logs was found to be false or incomplete. From 10 June, visitors to those indoor venues such as nightclubs, Karaoke clubs, and gyms will be required to use an app that generates a one-time personalized QR code that can be scanned at the door. Utilizing QR code technology is basically a tokenization that helps to collect visitors’ information and recall the information in case of an emergency.

However, this tokenization technology is likely to encounter a problem of limited coverage that is disrupting the national roll-out. Since it requires an active network connection for generating tokens, visitors who use entertainment venues located in the basement often experience serious latency during the code generation process. In addition, the more device connected to a network, the larger its attack surface grows, making easier for hackers to infiltrate the network. This can bring serious consequences like a breach of personal data. Some may question why individuals should bear the cost of mobile data for a service they are reluctant to use. On the other hand, the current system also causes technical challenges to QR code providers. They are required to be equipped with a great level of server capacity and computing resources in order to handle massive overhead from storing to encrypting/decrypting the tokens and information.   

How current QR code tracing works? How OTAC QR code tracing works?
How current QR code tracing works? How OTAC QR code tracing works?

swIDch‘s OTAC (One Time Authentication Code) technology can be an alternative solution, tackling the network connection issue of the QR code tracking system. This patented algorithm of OTAC enables to generate dynamic QR code on visitors’ smartphone even in off-the-network environment. Since OTAC does not require an active network connection, it can secure visitors information from hacking. In addition, it removes friction from user journeys by reducing heavy network traffic for generating tokens and server loads for persisting token details. In other words, system operators can save significant resources for processing tokens. As a result, the government can operate the system with larger coverage with less technical challenges.

The nationwide rollout is the key to efficiently operate the tracking system. Even though it is compulsory by the government, frictionless use of the system should be supported to encourage citizen’s participation. swIDch believes that OTAC can increase adoption and use of the QR code tracking system by providing uninterrupted, safe, and easy use of the system. The company actively proposes the solution to other states typically in developing countries where a network connection is unstable. Inspired by UN’s Sustainable Development Goals (SDGs), the company is willing to distribute its technology for free to any other country upon its requirement to tackle the global COVID-19 crisis together.

For more detailed information on swIDch, visit https://swidch.com/.

About swIDch

swIDch Ltd. (www.swidch.com) is a cybersecurity start-up based in London with R&D center in South Korea. The company helps businesses to identify and authenticate its users through our patented algorithm, one-time authentication code that generates in a networkless environment, to tackle problems of identity theft and CNP frauds. It is a security feature for uninterrupted use of devices by combining user identification and authentication steps into one only with the dynamic authentication code. Since its foundation in 2018, the company has chosen for the leading accelerator programmes in Europe and Asia – LORCA, Global Entrepreneur Programme, and Accenture FinTech Innovation Lab. Furthermore, swIDch gained global recognition for its innovative authentication technology, selected for XTC (Extreme Tech Challenge) finalist, winner of the hottest Cybertech Company from Europas 2020, and the annual list of the world’s most innovative Cybertech Company ‘Cybertech100’. 

About Born2Global Centre

Born2Global Centre (www.born2global.com) is a full-cycle service platform for global expansion. Since inception in 2013, Born2Global has been setting the standard for successful startup ecosystem as the main Korean government agency under the Ministry of Science and ICT. Born2Global has expanded and transformed startups to be engaged, equipped and be connected with the global market.

Media contact

swIDch: heesung@swidch.com 
Born2Global Centre: jlee@born2global.com

PR Newswire

TurtleTree Labs raises US$3.2 million seed round as it accelerates cell-based milk development

Leave a comment

SINGAPORE, June 25, 2020 — Singapore-based biotech company TurtleTree Labs today announced the completion of a fresh round of funding from global investors. TurtleTree Labs is the world’s first-cell based biotechnology company creating real milk from mammalian cells, without the need for animals. As a platform, the company’s focus is on high value human breast milk followed by cow milk.

TurtleTree Labs Founders Max Rye and Fengru Lin
TurtleTree Labs Founders Max Rye and Fengru Lin

 

Over the past year TurtleTree Labs has attracted world class talent, currently boasting a team of more than 20 full-time scientists and engineers. With multiple cross-functional teams working in parallel, co-founder and CEO Fengru Lin says, “Our team is hungry, passionate and knows what it takes to accelerate to market. I’m so inspired when even the most junior scientists are sharing ideas of cutting costs or identifying better suppliers.”

With support from the Singaporean government, the startup has been privy to an array of resources that provided TurtleTree Labs with a tremendous financial boost, enabling it to continue working during the COVID-19 pandemic. Co-founder Max Rye, originally from the San Francisco Bay area explains, “Our teams are firing on all cylinders thanks to Enterprise Singapore and the support from our investors. We remain as focused as ever, and we aim to continue hitting milestones.”

“TurtleTree Labs’ goal of creating milk from animal cells provides a novel solution towards sustainable dairy production globally, and would also help to strengthen Singapore’s long-term food diversification efforts. We are encouraged that Singapore’s foodtech infrastructure has enabled homegrown startups like TurtleTree Labs to push technological boundaries and obtain quick access to capital. We will continue our efforts to develop a vibrant agri-food tech ecosystem in Singapore to encourage the creation of more innovative solutions,” said Ms Bernice Tay, Director, Food Manufacturing Division, Enterprise Singapore.

Investors taking part in the TurtleTree Labs seed round are Green Monday Ventures, KBW Ventures, CPT Capital, Artesian, and New Luna Ventures.

“Food tech innovation in Asia is way overdue. If the rapidly deteriorating climate change situation isn’t enough to convince the world, the pandemic surely hammers home the urgency that we need to overhaul the food system for the sake of public health, food safety, and food security. That explains why Green Monday Ventures is so excited to invest in and collaborate with TurtleTree Labs.  We see immense possibilities in their biotech innovation platform, as well as enormous impact we can drive together,” says David Yeung, founder, Green Monday Group

“KBW Ventures has invested in the seed round building on our initial commitment during TurtleTree’s pre-seed raise. We see the founding team commitment and the potential of this company and its technology as a winning combination. Now more than ever, people are waking up to the benefits of food technology and the massive positive implications of innovations in cellular agriculture,” said Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures.

TurtleTree Labs raised its initial investment which was led by New York–Hong Kong based Lever VC in 2019, with investors from various geographies. “This fresh round of funding will enhance our scale up development, bringing us one step closer to commercialization,” said Max Rye.

For information and interview requests contact: pr@turtletreelabs.com

TurtleTree Labs – TurtleTree Labs is the first biotech company in the world with the ability to create milk from all mammals. Using their proprietary cell-based methods, they will shape the future of not just how we get dairy milk but how humans will feed their infants. To maximise impact, the team will work with industry leaders to adopt their sustainable and safe methods to create milk.  Their focus on impact will disrupt this multi-billion dollar industry while reducing the carbon footprint on this planet, while creating milk free of contaminants. Their innovation will provide millions access to safer, reliable and higher quality dairy products.

Green Monday Ventures – Green Monday Group has an overall mission to “Make Change Happen, Make Green Common” since its establishment in 2012. It is achieved by promoting plant-based eating and environmental protection through its multifaceted social venture model, in hopes of tackling climate change, global food in security and promoting public health. Green Monday Foundation, Green Monday Holdings and Green Monday Ventures are the three main branches of Green Monday Group. Green Monday Ventures is the impact investment arm aimed at accelerating the growth of mission-aligned entrepreneurs and startups globally.

KBW Ventures – KBW Ventures, founded by Chief Executive Officer HRH Prince Khaled bin Alwaleed bin Talal Al Saud, invests in companies with transformative technologies and business models and the potential for significant financial returns while also delivering positive social impact. The KBW Ventures portfolio spans the venture capital spectrum from earlier stage ventures, to more established companies looking to expand into the Middle East. 

CPT Capital – CPT Capital is the venture arm of a leading private family office. As a long-standing dedicated investor in the alternative protein space, CPT Capital has unmatched experience and expertise investing in companies disrupting the food system.

Artesian – Artesian is a full-stack VC firm investing from seed stage through to exit. The Artesian portfolio comprises over 400 investments across Australia, China, South East Asia, South Asia and the Americas.

New Luna Ventures – New Luna Ventures is a leading impact venture capital advisor and investor in the food 2.0, agriculture, energy, community enrichment, and enabling software industries. We help entrepreneurs build sustainable ventures and connect disruptive ideas with investors and partners. Together, we provide actionable plans, enhanced communications, and expanded access to markets.